ADK and cancer: While we, for the first time, revealed the expression profile of ADK isoforms in breast cancer and several tumor subtypes, the present study has limitations, particularly the relatively small patient sample size and lack of direct immunohistological evaluation of the subcellular distribution of ADK isoforms in cancer tissues.